Stabilized recombinant trefoil factor 2 (TFF2-CTP) enhances anti-tumor activity of PD-1 blockade in mouse models of colorectal cancer

被引：0
|
作者：
Kim, Woosook [1 ]
Fu, Na [1 ]
Duddempudi, Phaneendra [2 ]
Dubeykovskaya, Zinaida [3 ]
Almo, Steven [2 ]
Guha, Chandan [2 ]
Lederman, Seth [4 ]
Wang, Timothy [1 ]
机构：
[1] Columbia Univ, Med Ctr, New York, NY USA
[2] Albert Einstein Coll Med, New York, NY USA
[3] NYU, New York, NY USA
[4] Tonix Pharmaceut Inc, New York, NY USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-6640
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6640
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Myeloid-Specific SHP-2 Ablation Induces Robust Anti-Tumor Immunity That Is Not Further Enhanced By PD-1 Blockade
    Christofides, Anthos
    Tijaro-Ovalle, Natalia M.
    Aksoylar, Halil-Ibrahim
    Pal, Rinku
    Mahmoud, Abdelrahman Aa
    Strauss, Laura
    Patsoukis, Nikolaos
    Boussiotis, Vassiliki A.
    BLOOD, 2020, 136
  • [42] Evaluating anti-tumor activity of the human anti-PD-1 antibody pembrolizumab using humanized mouse models
    Linn, Douglas E.
    Cristescu, Razvan
    Ray, Kallol
    Zhang, Shuli
    Dhandapani, Sripriya
    Kaliyaperumal, Sarav
    Yearley, Jennifer H.
    Long, Brian J.
    CANCER RESEARCH, 2017, 77
  • [43] Improved survival with erdafitinib (JNJ-42756493) and PD-1 blockade mediated by enhancement of anti-tumor immunity in an FGFR2-driven genetically engineered mouse model of lung cancer
    Palakurthi, Sangeetha
    Kuraguchi, Mari
    Zacharek, Sima
    Liu, Jeff
    Bonal, Dennis
    Huang, Wei
    Depeaux, Kristin
    Dhaneshwar, Abha
    Regan, Sam
    Bailey, Dyane
    Gowaski, Martha
    Zheng, Mei
    Bronson, Roderick
    Ferrante, Catherine
    Zudaire, Enrique
    Laquerre, Sylvie
    Bittinger, Mark
    Paul, Kirschmeier
    Packman, Kathryn
    Verona, Raluca I.
    Wong, Kwok-Kin
    Lorenzi, Matthew V.
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03)
  • [44] Armoring CAR-T therapy with PD-1 blockade: a powerful strategy for enhancing anti-tumor effects in pancreatic cancer
    Zhang, Zhixiang
    Huang, Jingwei
    Zhao, Zhifeng
    Wang, Xiangyi
    He, Cnhui
    Yang, Sen
    Gu, Qingyang
    CANCER RESEARCH, 2024, 84 (06)
  • [45] Staged anti-PD-1 therapy with intratumoral recombinant calreticulin improves anti-tumor immunity and survival in glioblastoma mouse models
    Taori, Suchet
    Noffsinger, Breanna
    Miller, Charlotte A.
    Xiao, Aizhen
    Manigat, Laryssa
    Zhong, Qing
    Harris, Tajie
    Purow, Benjamin
    CANCER RESEARCH, 2022, 82 (12)
  • [46] Treatment with a VEGFR-2 antibody results in intra-tumor immune modulation and enhances anti-tumor efficacy of PD-L1 blockade in syngeneic murine tumor models
    Li, Yanxia
    Amaladas, Nelusha
    O'Mahony, Marguerita
    Manro, Jason R.
    Inigo, Ivan
    Li, Qi
    Rasmussen, Erik R.
    Brahmachary, Manisha
    Doman, Thompson N.
    Hall, Gerald
    Kalos, Michael
    Novosiadly, Ruslan
    Puig, Oscar
    Pytowski, Bronislaw
    Schaer, David A.
    PLOS ONE, 2022, 17 (07):
  • [47] Vaccination enhances anti-tumor immunity in ovarian cancer following repolarization of the tumor microenvironment with CCR2 blockade
    Cullinan, Darren
    Binder, Pratibha
    Nywening, Timothy
    Wilkinson-Ryan, Ivy
    Belt, Brian
    Goedegebuure, Peter
    Linehan, David
    Powell, Matthew
    Hawkins, William
    CANCER RESEARCH, 2016, 76
  • [48] An engineered IL-21 with half-life extension enhances anti-tumor immunity as a monotherapy or in combination with PD-1 or TIGIT blockade
    Liu, Hongchuan
    Wang, Rui
    An, Duopeng
    Liu, Hui
    Ye, Fan
    Li, Baoxian
    Zhang, Jing
    Liu, Peixiang
    Zhang, Xuyao
    Yao, Sheng
    Zhong, Ziyang
    Feng, Hui
    Feng, Meiqing
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 101
  • [49] Combined Radiation and PI3Kgd Inhibitor Enhances Anti-Tumor Effect of PD-1 Blockade in Immune-competent Syngeneic Breast Cancer Model
    Han, M. G.
    Jang, B. S.
    Kang, M. H.
    Chang, W. I.
    Kim, I. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S109 - S110
  • [50] Combination therapy with PD-1 inhibition plus rapamycin and metformin enhances anti-tumor efficacy in triple negative breast cancer
    Tan, Xiaoying
    Li, Yan
    Hou, Zhihui
    Zhang, Mingwei
    Li, Li
    Wei, Junmin
    EXPERIMENTAL CELL RESEARCH, 2023, 429 (01)
12345